Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2024. Start Trial.
Date Value
October 30, 2026 -47.20M
October 29, 2026 -44.00M
October 28, 2026 -44.00M
October 27, 2026 -65.51M
October 26, 2026 -87.48M
October 23, 2026 -82.45M
October 22, 2026 -62.76M
October 21, 2026 -63.68M
October 20, 2026 -61.39M
October 19, 2026 -87.48M
October 16, 2026 -94.35M
October 15, 2026 -71.00M
October 14, 2026 -67.80M
October 13, 2026 -60.93M
October 12, 2026 -44.00M
October 09, 2026 -25.68M
October 08, 2026 -31.64M
October 07, 2026 -29.35M
October 06, 2026 -27.97M
October 05, 2026 -24.77M
October 02, 2026 -13.32M
October 01, 2026 -4.169M
September 30, 2026 8.648M
September 29, 2026 10.94M
September 28, 2026 12.77M
Date Value
September 25, 2026 6.817M
September 24, 2026 14.14M
September 23, 2026 45.27M
September 22, 2026 71.36M
September 21, 2026 54.43M
September 18, 2026 53.05M
September 17, 2026 54.43M
September 16, 2026 38.86M
September 15, 2026 58.54M
September 14, 2026 72.28M
September 11, 2026 72.74M
September 10, 2026 80.06M
September 09, 2026 103.86M
September 08, 2026 114.16M
September 04, 2026 123.09M
September 03, 2026 118.97M
September 02, 2026 129.50M
September 01, 2026 119.89M
August 31, 2026 118.97M
August 28, 2026 125.84M
August 27, 2026 145.52M
August 26, 2026 134.53M
August 25, 2026 146.89M
August 24, 2026 113.48M
August 21, 2026 118.06M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Neumora Therapeutics, Inc. 5.030M
Alumis, Inc. 398.98M
ANI Pharmaceuticals, Inc. 1.889B
Corcept Therapeutics, Inc. 8.456B
Veru, Inc. 14.23M